Zoono Group (ZNO.AX) Stock Price
Zoono Group Price
Zoono Group (ZNO.AX) Stock | ISIN AU000000ZNO4 | WKN A2PZCA. The current Zoono Group stock price is 0.07 NZD (2026). Market capitalization is 26.32 M NZD. Zoono Group operates in the Commodities sector.
Over the last 19 years Zoono Group grew revenue by 3.8% annually, reaching 1.29 M NZD. Earnings per share have declined at 29.9% per year over the last 11 years. For Zoono Group, the net margin of -303.4% is down versus 17.4% a few years ago. At today's price the dividend yield works out to roughly 40.93%. The payout ratio is around 30% of earnings.
Zoono Group stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Zoono Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Zoono Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Zoono Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Zoono Group Price |
|---|
Zoono Group Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Zoono Group Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M NZD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M NZD) |
| NET INCOME (M NZD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 2 | 1 | 38 | 27 | 9 | 3 | 1 | 1 |
| – | -50 | 3,700 | -28.95 | -66.67 | -66.67 | -66.67 | – |
| 50 | 100 | 73.68 | 59.26 | 55.56 | 33.33 | 100 | 100 |
| 1 | 1 | 28 | 16 | 5 | 1 | 1 | 1 |
| 0 | -2 | 16 | 4 | -11 | 0 | -9 | -3 |
| – | – | -900 | -75 | -375 | – | – | -66.67 |
| 163.01 | 163.1 | 166.3 | 218.96 | 219.28 | 221.53 | 219.37 | 359.03 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Zoono Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Zoono Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Zoono Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Zoono Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Zoono Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Zoono Group stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Zoono Group Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Zoono Group business model & stock analysis
Zoono Group SWOT Analysis
Strengths
Zoono Group Ltd has a strong intellectual property portfolio, with multiple patents and trademarks, providing a competitive advantage in the market. This robust IP protection allows the company to maintain exclusivity over its unique products.
The company has a diverse and innovative product range, offering a wide variety of antimicrobial solutions that cater to different industries and applications. This versatility enables Zoono Group Ltd to effectively target multiple market segments and meet various customer needs.
Weaknesses
Zoono Group Ltd is relatively smaller in size compared to some of its competitors, which limits its financial resources and market reach. This can pose challenges in terms of expanding operations, conducting extensive research and development, and penetrating new markets.
The company heavily relies on third-party distributors and resellers to sell its products, which can result in reduced control over the sales process and potential inconsistencies in brand representation. This dependency exposes Zoono Group Ltd to risks associated with the performance and reliability of its distribution channels.
Opportunities
Growing global concern over hygiene and infectious diseases presents a significant opportunity for Zoono Group Ltd to capitalize on its antimicrobial solutions. The company can leverage this increasing demand to expand its customer base and penetrate new industries, such as healthcare, transportation, hospitality, and food processing.
Incorporating its antimicrobial technology into various consumer products, such as personal care items, clothing, and household goods, can open up new revenue streams for Zoono Group Ltd. By partnering with established brands, the company can enhance its market visibility and boost product adoption.
Threats
Intense competition within the antimicrobial industry poses a threat to Zoono Group Ltd. Other companies, including both large multinational corporations and smaller startups, are continuously developing and marketing their own antimicrobial solutions, potentially eroding Zoono's market share.
Regulatory compliance and approvals can present challenges for Zoono Group Ltd, as antimicrobial products are subject to stringent testing and certification processes. Delays or failures in obtaining necessary approvals may hinder the company's ability to launch new products or enter specific markets.
Zoono Group Eulerpool Fair Value
Zoono Group historical P/E ratio, EBIT multiple, and P/S ratio
Zoono Group annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Zoono Group shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Zoono Group Dividend History
2 years of dividend payments
Zoono Group dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Zoono Group shareholder structure
| % | Name |
|---|---|
33.24797% | |
9.70184% | |
6.52776% | |
5.34592% | |
1.38575% | |
1.14724% | |
1.07712% | |
1.00272% | |
0.99496% | |
0.7877% |
Zoono Group Executives and Management Board
Mr. Paul Hyslop
(65)Managing Director, Executive Director · since 2017
Mr. Paul Ravlich
Chief Financial Officer
Mr. Lewis Mackinnon
Group Chief Operating Officer
Ms. Elissa Hansen
(50)Company Secretary, Independent Non-Executive Director
Mr. Don Clarke
(69)Independent Non-Executive Director
Zoono Group Supply Chain
Frequently asked questions about Zoono Group
The business model of Zoono Group Ltd revolves around the development, manufacture, and distribution of a range of antimicrobial solutions. Zoono Group focuses on creating and marketing innovative long-lasting disinfectant products for various applications, including commercial, industrial, and personal use. Their scientifically advanced formulations provide a protective barrier against harmful microbes, delivering extended germ protection. Zoono's products have gained recognition for their effectiveness, durability, and environmentally friendly features. As a leading company in the antimicrobial industry, Zoono Group Ltd continually strives to enhance their product portfolio and expand their global presence.
Zoono Group stock
Zoono Group Peer Group
Zoono Group Ticker
Zoono Group FIGI
All fundamentals and in-depth analysis of Zoono Group
Our stock analysis for Zoono Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zoono Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.